Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Dhanlaxmi Crop Science Ltd. (DHANLAXMI.NS)
Himatnagar, GU, IN
Dhanlaxmi Crop Science Ltd. is an Indian enterprise specializing in the manufacture and processing of agricultural seeds. Established in 1994 and based in Himatnagar, India, the company boasts a comprehensive portfolio of crop and vegetable seeds. This includes a diverse array of offerings such as cotton, wheat, maize, soybeans, groundnut, and mustard, alongside numerous vegetable varieties like okra, green peas, and onions, as well as seeds for animal feed. Furthermore, Dhanlaxmi Crop Science extends its services to include expert consultancy for farmers and various agricultural businesses.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -11.64% | -12.30% | -7.36% | +15.85% | -11.64% | -3.90% | -47.19% | -73.02% | -73.02% | -73.02% | -73.02% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Agricultural Farm Products: +8.2%+103.0% ★
-
EPS growth Agricultural Farm Products: +20.0%+85.2% ★
-
FCF margin FCF growth · Agricultural Farm Products: +43.8%-10.0% Q3'25: -60.7%
-
EBIT margin Agricultural Farm Products: +8.1%+9.6% ★ Q3'25: +23.2%
-
ROIC Agricultural Farm Products: +6.0%+23.4% ★ Q3'25: +32.6%
-
Share dilution Agricultural Farm Products: +0.0%+0.0%
-
Debt / EBITDA Net debt/EBITDA · Agricultural Farm Products: 0.61×0.57× ★ Q3'25: 0.40×
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alpeshbhai Jayantibhai Patel | Joint MD & Executive Director | — | male |
| Chhayaben Ankitkumar Pujara | Company Secretary & Compliance Officer | — | female |
| Fula Bhila Patil | Head of Research & Development | — | male |
| Kamleshkumar Jayantilal Patel | MD & Executive Chairman | — | male |
| Meet Kamleshkumarbhai Patel | Whole Time Director & Executive Director of Marketing | — | male |
| Pankaj Dahyabhai Patel | Director of Sales & Accounts and Whole Time Director | — | male |
| Pooja Vimal Dave | Chief Financial Officer & Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DHANLAXMI.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
